To study the potential involvement of RIP3 in the activation of NLRP3 underlying sarcopenia in dependent patients, we examined the levels of RIP3 protein expression in skeletal muscle lysates by Western blot analysis. The gene discussed is RIPK3; the disease is sarcopenia.